These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1339 related items for PubMed ID: 29365054
1. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H. Carcinogenesis; 2018 Jul 03; 39(7):900-910. PubMed ID: 29365054 [Abstract] [Full Text] [Related]
2. GP73 promotes invasion and metastasis of bladder cancer by regulating the epithelial-mesenchymal transition through the TGF-β1/Smad2 signalling pathway. Yang HJ, Liu GL, Liu B, Liu T. J Cell Mol Med; 2018 Mar 03; 22(3):1650-1665. PubMed ID: 29349903 [Abstract] [Full Text] [Related]
3. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway. Wang J, Fan Z, Li J, Yang J, Liu X, Cheng J. Bioengineered; 2021 Dec 03; 12(1):3566-3577. PubMed ID: 34281492 [Abstract] [Full Text] [Related]
4. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, Shen G, Jia H. J Transl Med; 2017 Aug 15; 15(1):176. PubMed ID: 28810875 [Abstract] [Full Text] [Related]
5. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG. Hepatology; 2013 Oct 15; 58(4):1349-61. PubMed ID: 23696034 [Abstract] [Full Text] [Related]
6. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma. Yang Y, Liu Q, Zhang H, Zhao H, Mao R, Li Z, Ya S, Jia C, Bao Y. Oncol Rep; 2017 Feb 15; 37(2):1182-1188. PubMed ID: 28075476 [Abstract] [Full Text] [Related]
7. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration. Wang B, Liu T, Wu JC, Luo SZ, Chen R, Lu LG, Xu MY. Biomed Pharmacother; 2018 Feb 15; 98():214-221. PubMed ID: 29268242 [Abstract] [Full Text] [Related]
8. miR-663a inhibits tumor growth and invasion by regulating TGF-β1 in hepatocellular carcinoma. Zhang C, Chen B, Jiao A, Li F, Sun N, Zhang G, Zhang J. BMC Cancer; 2018 Nov 28; 18(1):1179. PubMed ID: 30486878 [Abstract] [Full Text] [Related]
9. Rce1 suppresses invasion and metastasis of hepatocellular carcinoma via epithelial-mesenchymal transition induced by the TGF-β1/H-Ras signaling pathway. Ma C, Yang Y, Xu L, Tu W, Chen F, Wang J. J Cell Physiol; 2020 Mar 28; 235(3):2506-2520. PubMed ID: 31506952 [Abstract] [Full Text] [Related]
10. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q. Biomed Pharmacother; 2018 Jul 28; 103():1632-1642. PubMed ID: 29864952 [Abstract] [Full Text] [Related]
12. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma. Zhou SJ, Liu FY, Zhang AH, Liang HF, Wang Y, Ma R, Jiang YH, Sun NF. Br J Cancer; 2017 Jul 11; 117(2):233-244. PubMed ID: 28588321 [Abstract] [Full Text] [Related]
13. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma. Chen J, Zhu H, Liu Q, Ning D, Zhang Z, Zhang L, Mo J, Du P, Liu X, Song S, Fan Y, Liang H, Liu J, Zhang B, Chen X. J Exp Clin Cancer Res; 2019 Jun 22; 38(1):273. PubMed ID: 31228948 [Abstract] [Full Text] [Related]
14. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGFβR Regulating TGF-β/Smad Pathway. Du H, Gu J, Peng Q, Wang X, Liu L, Shu X, He Q, Tan Y. Oxid Med Cell Longev; 2021 Jun 22; 2021():2337818. PubMed ID: 34712379 [Abstract] [Full Text] [Related]
15. FCN2 inhibits epithelial-mesenchymal transition-induced metastasis of hepatocellular carcinoma via TGF-β/Smad signaling. Yang G, Liang Y, Zheng T, Song R, Wang J, Shi H, Sun B, Xie C, Li Y, Han J, Pan S, Lan Y, Liu X, Zhu M, Wang Y, Liu L. Cancer Lett; 2016 Aug 10; 378(2):80-6. PubMed ID: 27177473 [Abstract] [Full Text] [Related]
17. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells. Kim YJ, Jeon Y, Kim T, Lim WC, Ham J, Park YN, Kim TJ, Ko H. Bioorg Med Chem Lett; 2017 Feb 15; 27(4):1081-1088. PubMed ID: 28110870 [Abstract] [Full Text] [Related]
18. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Feng XJ, Pan Q, Wang SM, Pan YC, Wang Q, Zhang HH, Zhu MH, Zhang SH. Tumour Biol; 2016 Aug 15; 37(8):11457-67. PubMed ID: 27010469 [Abstract] [Full Text] [Related]
19. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3. Wang Y, Li N, Zheng Y, Wang A, Yu C, Song Z, Wang S, Sun Y, Zheng L, Wang G, Liu L, Yi J, Huang Y, Zhang M, Bao Y, Sun L. Int J Mol Sci; 2021 Dec 22; 23(1):. PubMed ID: 35008530 [Abstract] [Full Text] [Related]